May 8, 2026 Opinion: I’m fighting misinformation online. False hantavirus claims follow a now-familiar playbook May 8, 2026 Cross Country Healthcare to be taken private by PE firm for $437M May 8, 2026 Federation of American Hospitals taps new government relations head May 8, 2026 Wegovy Pill Shatters Launch Records as Novo Nordisk and Eli Lilly Battle for America’s $100 Billion Weight-Loss Market May 8, 2026 The biotechs wear Prada May 8, 2026 STAT+: The biotech news you need to read today May 8, 2026 STAT+: Pharmalittle: We’re reading about an FDA gender rule change, its program for one-day inspections, and more May 8, 2026 The aging scientific workforce collides with rising fabricating citations in medical journals May 8, 2026 Why we left the FDA: Six former officials share their stories May 8, 2026 Opinion: STAT+: Medicare’s new RAPID pathway is a breakthrough for adults. Children are still waiting May 8, 2026 Opinion: We need more men in nursing May 7, 2026 Fraudulent citations, blamed on AI hallucinations, are becoming more common in research papers May 7, 2026 White House Drug Strategy Pledges Addiction Help While Cutting the Funds to Deliver It May 7, 2026 Key takeaways from WHO briefing on hantavirus cruise ship outbreak May 7, 2026 Science is becoming less disruptive. Is an aging workforce to blame? May 7, 2026 Seaport’s IPO adventure, obesity pill battles, and Makary’s troubles May 7, 2026 Official leading CDC’s cruise ship program retires May 7, 2026 STAT+: FDA revisits a rare cancer treatment it rejected a few months ago May 7, 2026 Amwell expects smaller losses in 2026 after Q1 performance May 7, 2026 Hospital at home linked to lower ED visits, in-hospital mortality: study May 7, 2026 STAT+: More political interference at the FDA? May 7, 2026 STAT+: Pharmalittle: We’re reading about Sanofi and an FDA voucher, FDA rethinking a rejection, and more May 7, 2026 FDA warns of neurosurgical supply disruptions May 7, 2026 STAT+: OpenAI’s health policy wishlist, CGM news from Dexcom, and more May 7, 2026 Cruise ship hantavirus outbreak worries experts, though they discount pandemic fears May 7, 2026 STAT+: FDA to reconsider treatment for rare cancer after its surprise rejection May 7, 2026 Hospital shootings steadily increased since 2000 May 7, 2026 CVS Health Raises Full-Year Outlook as Aetna’s Turnaround Takes Hold May 7, 2026 STAT+: Next-gen Duchenne drug from Entrada disappoints May 7, 2026 STAT+: Color me skeptical: Drinking gold is not an ALS cure May 7, 2026 Opinion: Eugene Braunwald, ‘father of modern cardiology,’ told me he had two dreams. One came true May 7, 2026 STAT+: What was lost at the FDA May 7, 2026 STAT+: Angelini Pharma buys Catalyst Pharmaceuticals and its rare disease drugs for $4.1B May 6, 2026 Johnson & Johnson Pushes IBD Drug Forward After Trial Falls Short of Key Targets May 6, 2026 STAT+: Oregon hospitals won’t outsource to national physician chain after all May 6, 2026 STAT+: Pharmalittle: We’re reading about RFK Jr. targeting antidepressants, J&J pushing an IBD drug, and more May 6, 2026 Trump administration’s drug strategy is at odds with recent actions on funding, policy May 6, 2026 STAT+: How a global effort to explore the ‘dark proteome’ is upending our understanding of human disease May 6, 2026 Why the FDA is authorizing fruit-flavored vapes May 6, 2026 STAT+: Color Health moving deeper into cancer services, complete with virtual ‘tumor boards’ Previous Page 1 … 24 25 26 27 28 … 40 Next Page 2026-03-30
